JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2012

Summary

“JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2012” provides data on the JCR Pharmaceuticals Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, JCR Pharmaceuticals Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from JCR Pharmaceuticals Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- JCR Pharmaceuticals Co., Ltd. - Brief JCR Pharmaceuticals Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of JCR Pharmaceuticals Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of JCR Pharmaceuticals Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the JCR Pharmaceuticals Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate JCR Pharmaceuticals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of JCR Pharmaceuticals Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the JCR Pharmaceuticals Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with JCR Pharmaceuticals Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of JCR Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas.

Table of Contents 2
List of Tables 4
List of Figures 4
JCR Pharmaceuticals Co., Ltd. Snapshot 5
JCR Pharmaceuticals Co., Ltd. Overview 5
Key Information 5
Key Facts 5
JCR Pharmaceuticals Co., Ltd. – Research and Development Overview 6
Key Therapeutic Areas 6
JCR Pharmaceuticals Co., Ltd. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
JCR Pharmaceuticals Co., Ltd. – Pipeline Products Glance 10
JCR Pharmaceuticals Co., Ltd. – Late Stage Pipeline 10
Registration Filed Products/Combination Treatment Modalities 10
JCR Pharmaceuticals Co., Ltd. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
JCR Pharmaceuticals Co., Ltd. – Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
JCR Pharmaceuticals Co., Ltd. – Drug Profiles 14
agalsidase alfa 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
idursulfase 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
JR-031 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
JR-041 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
somatropin 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
taliglucerase alfa 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
JCR Pharmaceuticals Co., Ltd. – Pipeline Products by Route of Administration 20
JCR Pharmaceuticals Co., Ltd. – Pipeline Products By Mechanism of Action 21
JCR Pharmaceuticals Co., Ltd. - Dormant Projects 22
JCR Pharmaceuticals Co., Ltd. – Company Statement 23
JCR Pharmaceuticals Co., Ltd. – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Financial Deals Landscape 26
JCR Pharmaceuticals Co., Ltd., Deals Summary 26
JCR Pharmaceuticals Co., Ltd., Pharmaceuticals & Healthcare, Deal Details 27
Asset Transactions 27
JCR Pharma Acquires Hormone Business From Dainippon Sumitomo Pharma 27
Partnerships 29
JCR Pharma Enters Into Co-Development Agreement With MediPal 29
JCR Pharma Enters Into An Agreement With TPG Biotech 30
JCR Pharma Enters Into Co-Development Agreement With Mochida Pharma 32
Licensing Agreements 34
GlaxoSmithKline Enters Into Licensing Agreement With JCR Pharma 34
ASKA Pharma Enters Into Licensing Agreement With JCR Pharma 35
Oxford Gene Enters Into Licensing Agreement With Bio Matrix Research And Filgen 37
Equity Offering 38
JCR Pharma Completes Private Placement With Kissei Pharma 38
BIO MATRIX RESEARCH Completes Private Placement To Cosmo Bio 40
Acquisition 41
GlaxoSmithKline Acquires Additional Stake In JCR Pharma 41
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44

List of Tables
JCR Pharmaceuticals Co., Ltd., Key Information 5
JCR Pharmaceuticals Co., Ltd., Key Facts 5
JCR Pharmaceuticals Co., Ltd. – Pipeline by Indication, 2012 7
JCR Pharmaceuticals Co., Ltd. – Pipeline by Stage of Development, 2012 8
JCR Pharmaceuticals Co., Ltd. – Monotherapy Products in Pipeline, 2012 9
JCR Pharmaceuticals Co., Ltd. – Filed, 2012 10
JCR Pharmaceuticals Co., Ltd. – Phase II, 2012 11
JCR Pharmaceuticals Co., Ltd. – Phase I, 2012 12
JCR Pharmaceuticals Co., Ltd. – Pre-Clinical, 2012 13
JCR Pharmaceuticals Co., Ltd. – Pipeline By Route of Administration, 2012 20
JCR Pharmaceuticals Co., Ltd. – Pipeline Products By Mechanism of Action, 2012 21
JCR Pharmaceuticals Co., Ltd. - Dormant Developmental Projects,2012 22
JCR Pharmaceuticals Co., Ltd., Other Locations 24
JCR Pharmaceuticals Co., Ltd., Subsidiaries 25
JCR Pharmaceuticals Co., Ltd., Deals Summary 26
JCR Pharma Acquires Hormone Business From Dainippon Sumitomo Pharma 27
JCR Pharma Enters Into Co-Development Agreement With MediPal 29
JCR Pharma Enters Into An Agreement With TPG Biotech 30
JCR Pharma Enters Into Co-Development Agreement With Mochida Pharma 32
GlaxoSmithKline Enters Into Licensing Agreement With JCR Pharma 34
ASKA Pharma Enters Into Licensing Agreement With JCR Pharma 35
Oxford Gene Enters Into Licensing Agreement With Bio Matrix Research And Filgen 37
JCR Pharma Completes Private Placement With Kissei Pharma 38
BIO MATRIX RESEARCH Completes Private Placement To Cosmo Bio 40
GlaxoSmithKline Acquires Additional Stake In JCR Pharma 41

List of Figures
JCR Pharmaceuticals Co., Ltd. – Pipeline by Indication, 2012 7
JCR Pharmaceuticals Co., Ltd. – Pipeline by Stage of Development, 2012 8
JCR Pharmaceuticals Co., Ltd. – Monotherapy Products in Pipeline, 2012 9
JCR Pharmaceuticals Co., Ltd. - Pipeline Products By Mechanism of Action, 2012 21